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Hypocalcemia is the most frequent major complication following total thyroidectomy (TT), delaying
timely hospital demission. We prospectively evaluated the diagnostic utility of parathyroid hormone
(PTH) measured one hour after TT and the delta (post-minus pre-surgery) PTH in order to determine
which biomarker best predicted post-surgery hypocalcemia.
Ninety-six consecutive patients, with either plurinodular goiter, Graves' disease or cervico-mediastinal
goiter (22 (23%) men and 74 (77%) women, mean age 48.5 ± 15.2 and 47.9 ± 13.2 years, respectively),
scheduled to undergo TT were enrolled. PTH was measured prior and one hour after surgery. Delta PTH
was deﬁned as one-hour post-surgery values minus pre-surgery PTH level. Hypocalcemia was deﬁned as
a calcemia under 8.0 mg/dL. Receiver operating characteristic (ROC) analysis was used to evaluate the
Area Under Curve (AUC), sensibility and speciﬁcity of the two biomarkers for the occurrence of hypo-
calcemia. Forty-nine (51%) patients presented biochemical values under the cut-off but only 17 (18%) had
clinical symptoms.
Both variables yielded statistically signiﬁcant AUC (PTH one-hour post surgery: 0.654; p ¼ 0.0403; 95%
CI: 0.519e0.773 and delta PTH: 0.659; p ¼ 0.0263; 95%CI: 0.527e0.776). Although comparison of the two
ROC curves did not yield signiﬁcant differences, delta PTH yielded a better sensitivity and PTH one-hour
post-TT yielded a marginally better speciﬁcity (sensitivity of 50% and 87% and speciﬁcity of 76% and 67%
for cut-offs of <39.8 pg/dl and <54.5 pg/dl, respectively).
Both biomarkers have similar diagnostic accuracy for hypocalcemia, and can be used to indicate when
supplemental therapy should be implemented in order to favor a timely discharge.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Total thyroidectomy (TT) is universally suggested for benign
pathologies [1] of the thyroid gland and accordingly the number of
these procedures has been increasing dramatically the last 10 years
[2]. Even if the most indicated surgical technique is used, the per-
centage of the most frequent post-operative complication, tran-
sient hypocalcemia, is high and represents the major cause of
premature failure, late discharge and hospital re-admissions [3].
Direct or indirect damage, by devascularization of the parathyroid
glands, is the main cause of hypocalcemia after TT, but several
factors affect the development of this complication [4].
Predictive information on the development of postoperative
hypocalcemia would permit the implementation of a series of
therapies aimed at reducing symptoms and preventing improper or
delayed discharge. Traditionally, daily monitoring of serum calciumental and Clinical Sciences,
tini, 66100 Chieti Scalo, Italy.
by Elsevier Ltd. All rights reservedhas been used. This biomarker can be altered even 24e48 h after
surgery. As part of an early and safe patient discharge, the dosage of
parathyroid hormone (PTH) was tested as a biomarker of post-
operative hypocalcemia, showing good sensitivity and speciﬁcity,
especially if dosed 1 h after surgery [5]. Even if the authors
demonstrated a strong correlation between PTH and postoperative
hypocalcemia, it was not possible to determine the absolute level of
PTH that was associated with hypocalcemia. That is because the
PTH level can be affected by many factors such as sex, hyperthy-
roidism, and Vit.D rate; factors that can affect the absolute dosage
of the hormone [6].
The aim of this study was to evaluate prospectively the PTH
dosage to 1 h by comparing the percentage of decline between pre-
and post-operative PTH in order to determine the best predictor of
hypocalcemia after total thyroidectomy.2. Methods
From June 2012 to June 2013, ninety-six consecutive patients
scheduled to undergoTTwere enrolled. The underlying diseasewas.
Fig. 2. Receiver operating characteristic curves for the one-hour post-operative PTH
levels as a diagnostic biomarker for hypocalcemia.
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cervico-mediastinal goiter (8 patients). The study population
included 22 (23%) men and 74 (77%) women, mean age 48.5 ± 15.2
and 47.9 ± 13.2 years, respectively.
Two endocrine surgeons using the same technique performed
the total thyroidectomy. PTH was measured one hour prior and
after surgery. Delta PTH was deﬁned as one-hour post-surgery
values minus pre-surgery PTH levels. Hypocalcemia was deﬁned as
a serum calcium level under 8.0 mg/dL 24-h post-surgery.
Receiver operating characteristic (ROC) analysis was used to
evaluate the Area Under Curve (AUC), sensibility and speciﬁcity of
two biomarkers for the occurrence of hypocalcemia were calcu-
lated using Medcalc version 13.
3. Results
No intraoperative complications and mortality were observed.
The average duration of surgery was 64 ± 16 min. Forty-nine (51%)
patients presented biochemical values under the cut-off but only 17
(18%) had clinical symptoms. The average hospitalization was 2 ± 1
days.
Both considered variables yielded statistically signiﬁcant AUC
(PTH one-hour post surgery: 0.654; p¼ 0.0403; 95%CI: 0.519e0.773
and delta PTH: 0.659; p ¼ 0.0263; 95%CI: 0.527e0.776).
(Figs. 1 and 2). Although comparison of the two ROC curves did
not yields signiﬁcant differences, delta PTH yielded a better
sensitivity and PTH one-hour post-TT yielded a marginally better
speciﬁcity (sensitivity and speciﬁcity of 50% and 87% and 76% and
67% for cut-offs of <39.8 pg/dl and <54.5 pg/dl, respectively)
(Figs. 1 and 2).
In the follow-up only one patient presented persistent
hypocalcaemia.
4. Discussion
The transient hypocalcemia remains the most frequent
complication after TT with an incidence ranging from 1.6 to 50% [7].
Direct or indirect damage to the parathyroid glands is the most
common cause of hypocalcemia and the damage appears to be inFig. 1. Receiver operating characteristic curves for the delta PTH (post-minus pre-
operative levels) as a diagnostic biomarker for hypocalcemia.most cases temporary, so that only 1e3% of cases will be affected by
a permanent hypocalcemia [8]. Apart from bleeding, hypocalcemia
is themost common cause of delayed discharge and/or readmission
after TT [9].
Knowing which patients will experience a hypocalcemia will
allow us to anticipate therapy in order to reduce symptoms and
guarantee a timely and safe discharge. Several studies have inves-
tigated predictors of hypocalcemia after TT with this aim. It was
reported that women and a diagnosis of Graves disease before
surgery [10], as well as people with a low level of Vit.D [11], have a
higher risk for post-operative hypocalcemia.
The possibility of using PTH dosage as a predictor of hypocal-
cemia after surgery has been proposed. Different protocols have
been implemented in order to identify the best timing and we
noticed that a single control between 10 m and 6 h is enough to
obtain a reliable result with good speciﬁcity and sensitivity [12].
The initial enthusiasm that led to think to be able to identify
with an accuracy of 100% the hypocalcemia, after surgery, dosing
the PTH has been progressively decreased, getting more and more
experience. Grodski et al. reported that 7% of patients with normal
PTH may experience hypocalcemia, although of moderate entity
[13]. It is also been reported that the rate of PTH can be altered by
diseases, such as Basedow disease, or conditions such as Vitamin D
deﬁcit [14]. It has been shown, in fact, that in patients with a deﬁcit
of vitamin D, the dosage of PTH after surgery is not useful as a
predictor of hypocalcemia. [15]
In order to overcome these limits, we wanted to compare the
dosage at one-hour with the decrease between pre- and post-
surgery PTH levels to identify the best biomarker of hypocalcemia
after TT. Our results indicate that hypocalcemia occurred in 51%
cases, but this ﬁgure is affected by the cut-off that we wanted to
give to normal serum calcium value (8 mg/dL). In fact, only 18% of
the patients had clinical symptoms, but 11 patients (11.4%) had
serum calcium between 7.5 and 7.9.
Our results indicated a statistically signiﬁcant AUC for both
the dosage of PTH one-hour and delta PTH. A comparison of the
two ROC curves did not present signiﬁcant differences although
there was a better speciﬁcity and sensitivity of the difference
between PTH pre PTH compared to one hour. In our experience
A. Bove et al. / International Journal of Surgery 12 (2014) S202eS204S204this ﬁgure is true especially for patients whose basic level of PTH
is abnormal.
The results of our study show lower values of speciﬁcity and
sensitivity compared to other studies [16] and we think that it may
be due in part to the percentage of patients with Graves disease
included in the case histories. Even Lombardi et al. [17] reported a
false-negative rate of 13.4% and concluded that the predictive value
is high only with PTH levels below 10 pg/ml, while in case of minor
reductions the datum is not accurate enough.
Some authors have proposed the replacement therapy of cal-
cium and vitamin D for all patients subjected to TT [18]. This
approach may lead to a reduction in the incidence and severity of
hypocalcemia after surgery, but it requires an “overtreatment” for
more than 50% of the patients, whose follow-up will be impacted
negatively thus increasing health expenses.
Ultimately both the studied biomarkers were effective in pre-
dicting hypocalcemia after surgery with a slightly better result
obtained with the delta PTH. Both biomarkers can be used to aid in
obtaining a safe and timely discharge after total thyroidectomy.
These results will require the identiﬁcation and classiﬁcation of
patients according to different clinical features before surgery in
order to maximize the diagnostic accuracy of these biomarkers.
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